lobbying_filings_raw: f8ad2a09-45d2-4ef6-a2f6-cd7aabe70fb7
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| f8ad2a09-45d2-4ef6-a2f6-cd7aabe70fb7 | Q4 | 34158 | FAEGRE BAKER DANIELS CONSULTING | 142641 | NATIONAL PSORIASIS FOUNDATION | 2014 | fourth_quarter | 2015-01-14T11:08:54.690000-05:00 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/f8ad2a09-45d2-4ef6-a2f6-cd7aabe70fb7/", "filing_uuid": "f8ad2a09-45d2-4ef6-a2f6-cd7aabe70fb7", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2014, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/f8ad2a09-45d2-4ef6-a2f6-cd7aabe70fb7/print/", "filing_document_content_type": "text/html", "income": null, "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "David Zook", "dt_posted": "2015-01-14T11:08:54.690000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1050 K STREET NW", "registrant_address_2": "SUITE 400", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20001", "registrant": {"id": 34158, "url": "https://lda.senate.gov/api/v1/registrants/34158/", "house_registrant_id": 30124, "name": "FAEGRE BAKER DANIELS CONSULTING", "description": "Consulting firm", "address_1": "1050 K Street NW", "address_2": "Suite 400", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20001", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "NICHOLAS MANETTO", "contact_telephone": "+1 202-312-7473", "dt_updated": "2022-04-06T16:08:31.313431-04:00"}, "client": {"id": 142641, "url": "https://lda.senate.gov/api/v1/clients/142641/", "client_id": 1005077, "name": "NATIONAL PSORIASIS FOUNDATION", "general_description": "Biomedical research; public health; appropriations", "client_government_entity": false, "client_self_select": null, "state": "OR", "state_display": "Oregon", "country": "US", "country_display": "United States of America", "ppb_state": "OR", "ppb_state_display": "Oregon", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2014-03-01"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Medical reimbursement levels; Appropriations", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 14340, "prefix": null, "prefix_display": null, "first_name": "NICK", "nickname": null, "middle_name": null, "last_name": "MANETTO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 48272, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": null, "last_name": "O'MALLEY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Appropriations; Public Health agenda for psoriasis and psoriatic arthritis; Patient's Access to Treatment Act; Part D Beneficiary Appeals Fairness Act; Medical reimbursement levels", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 14340, "prefix": null, "prefix_display": null, "first_name": "NICK", "nickname": null, "middle_name": null, "last_name": "MANETTO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 48272, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": null, "last_name": "O'MALLEY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 30124 | OR | OR | US | US | Biomedical research; public health; appropriations | 0 | 0 |